These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Significant association of MCP1 rs1024611 and CCR2 rs1799864 polymorphisms with colorectal cancer and liver metastases susceptibility and aggressiveness: A case-control study. Boughriba R, Sahraoui G, Chaar I, Weslati M, Ayed K, Ounissi D, Hazgui M, Bouraoui S, Gati A. Cytokine; 2023 Jul; 167():156193. PubMed ID: 37149962 [Abstract] [Full Text] [Related]
3. Frequency of MCP-1 (rs1024611) and CCR2 (rs1799864) gene polymorphisms and its effect on gene expression level in patients with AgP. Gunpinar S, Alptekin NO, Ucar VB, Acar H. Arch Oral Biol; 2017 Aug; 80():209-216. PubMed ID: 28458180 [Abstract] [Full Text] [Related]
4. The impact of MCP1-2518A/G and CCR2-V64I genetic polymorphisms in Egyptian sickle cell disease patients. Ibrahim NS, Makhlouf MM, Shahin GH, Elghamrawy MK, Hussein NM. Exp Mol Pathol; 2022 Oct; 128():104834. PubMed ID: 36155203 [Abstract] [Full Text] [Related]
5. Genetic variants of chemokine CCL2 and chemokine receptor CCR2 genes and risk of prostate cancer. Mandal RK, Agrawal T, Mittal RD. Tumour Biol; 2015 Jan; 36(1):375-81. PubMed ID: 25266801 [Abstract] [Full Text] [Related]
6. Association of polymorphisms in the MCP-1 and CCR2 genes with the risk of cancer: a meta-analysis. Cho YA, Kim J. Cytokine; 2013 Oct; 64(1):213-20. PubMed ID: 23876399 [Abstract] [Full Text] [Related]
7. Association of the MCP-1 -2518 A/G polymorphism and no association of its receptor CCR2 -64 V/I polymorphism with lupus nephritis. Malafronte P, Vieira JM, Pereira AC, Krieger JE, Barros RT, Woronik V. J Rheumatol; 2010 Apr; 37(4):776-82. PubMed ID: 20231199 [Abstract] [Full Text] [Related]
8. Single nucleotide polymorphisms in monocyte chemoattractant protein-1 and its receptor act synergistically to increase the risk of carotid atherosclerosis. Nyquist PA, Winkler CA, McKenzie LM, Yanek LR, Becker LC, Becker DM. Cerebrovasc Dis; 2009 Apr; 28(2):124-30. PubMed ID: 19506371 [Abstract] [Full Text] [Related]
9. Association of CCL2, CCR2 and CCL5 genetic polymorphisms with the development and progression of benign prostatic hyperplasia. Pang Y, Li H, Gong Y, Jing S, Peng C, Liu W, Zhao Y, Wang H, Kaushik D, Rodriguez R, Wang Z. Oncol Rep; 2019 Apr; 41(4):2491-2501. PubMed ID: 30816510 [Abstract] [Full Text] [Related]
10. Association of CCL2 and CCR2 gene variants with endometrial cancer in Turkish women. Attar R, Agachan B, Kuran SB, Cacina C, Sozen S, Yurdum LM, Attar E, Isbir T. In Vivo; 2010 Apr; 24(2):243-8. PubMed ID: 20364004 [Abstract] [Full Text] [Related]
11. Relationships of single nucleotide polymorphisms of monocyte chemoattractant protein 1 and chemokine receptor 2 with susceptibility and clinicopathologic characteristics of neoplasia of uterine cervix in Taiwan women. Wu HH, Lee TH, Tee YT, Chen SC, Yang SF, Lee SK, Ko JL, Wang PH. Reprod Sci; 2013 Oct; 20(10):1175-83. PubMed ID: 23427179 [Abstract] [Full Text] [Related]
12. Association of genetic polymorphisms of chemokines and their receptors with clearance or persistence of hepatitis C virus infection. El-Bendary M, Neamatallah M, Elalfy H, Besheer T, El-Setouhy M, Youssef MM, Zein M, Elhammady D, Hegazy A, Esmat G. Br J Biomed Sci; 2019 Jan; 76(1):11-16. PubMed ID: 30175654 [Abstract] [Full Text] [Related]
13. The association of monocyte chemotactic protein-1 and CC chemokine receptor 2 gene variants with chronic obstructive pulmonary disease. Bai J, Song H, Cai C, Zhang M, Xu S, Tan J. DNA Cell Biol; 2012 Jun; 31(6):1058-63. PubMed ID: 22276574 [Abstract] [Full Text] [Related]
14. [Association of chemokines and their receptors genes polymorphisms with risk of myocardial infarction]. Xu X, Wang LH, Liu HB, Xu CF, Zhang P, Yong F, Shi YP. Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2013 Oct; 30(5):601-7. PubMed ID: 24078580 [Abstract] [Full Text] [Related]
15. The +190 G/A (rs1799864) polymorphism in the C-C chemokine receptor 2 (CCR2) gene is associated with susceptibility to multiple sclerosis in HLA-DRB1*15:01-negative individuals. Javor J, Párnická Z, Michalik J, Čopíková-Cudráková D, Shawkatová I, Ďurmanová V, Gmitterová K, Klímová E, Bucová M, Buc M. J Neurol Sci; 2015 Feb 15; 349(1-2):138-42. PubMed ID: 25604634 [Abstract] [Full Text] [Related]
16. Association of polymorphisms in MCP-1, CCR2, and CCR5 genes with the risk and clinicopathological characteristics of prostate cancer. Kucukgergin C, Isman FK, Cakmakoglu B, Sanli O, Seckin S. DNA Cell Biol; 2012 Aug 15; 31(8):1418-24. PubMed ID: 22612293 [Abstract] [Full Text] [Related]
17. The Frequency of Monocyte Chemoattractant Protein-1 Gene Polymorphism in Obstructive Sleep Apnea Syndrome. Kerget B, Araz O, Erdem HB, Akgün M. Lung; 2019 Oct 15; 197(5):585-592. PubMed ID: 31388753 [Abstract] [Full Text] [Related]
18. The role of chemokine and chemokine receptor gene variants on the susceptibility and clinicopathological characteristics of bladder cancer. Kucukgergin C, Isman FK, Dasdemir S, Cakmakoglu B, Sanli O, Gokkusu C, Seckin S. Gene; 2012 Dec 10; 511(1):7-11. PubMed ID: 22982413 [Abstract] [Full Text] [Related]
19. Monocyte chemotactic protein-1 and CC chemokine receptor 2 polymorphisms and prognosis of renal cell carcinoma. Liu GX, Zhang X, Li S, Koiiche RD, Sindsceii JH, Song H. Tumour Biol; 2013 Oct 10; 34(5):2741-6. PubMed ID: 23657965 [Abstract] [Full Text] [Related]
20. Lack of association between monocyte protein-1 (MCP-1) -2518 A>G chemoattractant and C-C chemokine receptor 2 (CCR2) Val64Ile polymorphisms and multiple sclerosis in a Tunisian population. Messadi A, Fekih-Mrissa N, Kallel A, Bouguerra C, Sediri Y, Zaweli J, Laayouni S, Nciri B, Yedeas M, Mrissa R, Jemaa R, Kaabachi N, Gritli N. J Clin Neurosci; 2010 Oct 10; 17(10):1311-3. PubMed ID: 20637631 [Abstract] [Full Text] [Related] Page: [Next] [New Search]